Columbia Asia to Invest 210 Million Dollar across Asia, India by 2020

Published On 2018-09-27 05:15 GMT   |   Update On 2018-09-27 05:15 GMT
Bangalore: Columbia Asia, a leading hospital chain in Asia, is all set to expand operations across Asia and India by 2020, utilizing the 210 million USD fund which Columbia Asia had raised in March 2018.

Columbia Asia's India revenue for FY 18 grew 16 per cent year-on-year and at a CAGR of 15 per cent over the last 4 years.

Columbia Asia presently has 30 medical facilities (about 2,600 beds) in 4 country namely Malaysia, India, Indonesia and Vietnam, serving more than 2.5 million outpatients yearly in fields of orthopedics, internal medicine, general surgery, pediatrics, and obstetrics & gynecology, which cover about 80% of the medical needs in these countries.

"Last year as a group, we grew stronger, with a 20 per cent year-on-year growth in revenues. We believe in adhering to a high standard of ethics - this has enabled us to gain the trust of patients and payers. We know that our model of care works well in India and we will continue our expansion plans to serve the people of India even better," said Dr Kelvin Loh, Group Chief Executive Officer, Columbia Asia.

"At Columbia Asia, we strive in providing effective healthcare at excellent value and to be the preferred choice for families and businesses. Our mission is to provide effective and affordable care in a clean and caring environment. Through the cluster strategies, we can realize economies of scale despite most of our hospitals have less than 200 beds. We also have the flexibility to tailor each hospital's expansion plan and medical program mix based on specific and localized demand and supply dynamics," said Dr Nanda Kumar Jairam, Chief Executive Officer, Columbia Asia India.

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News